What is Hexoskin?
Founded in 2006, Hexoskin has established itself as a leader in the development of non-invasive sensors, software, and data science services. The company specializes in providing actionable health intelligence through wearable technology, serving a diverse clientele that includes first responders, pharmaceutical companies, and academic institutions. By integrating sophisticated AI services with hardware, Hexoskin enables real-time physiological monitoring that is essential for security, defense, and healthcare applications. Its market position is defined by its commitment to precision and reliability, ensuring that complex biometric data is translated into meaningful insights for mission-critical environments.
How much funding has Hexoskin raised?
Hexoskin has raised a total of $5.5M across 2 funding rounds:
Angel/Seed
$1.3M
Other Financing Round
$4.2M
Angel/Seed (2015): $1.3M with participation from Anges Québec
Other Financing Round (2024): $4.2M led by AQC Capital, BDC Capital Management, and Anges Québec
Key Investors in Hexoskin
AQC Capital
AQC Capital is a venture firm focused on supporting Quebec-based startups, providing both financial resources and strategic guidance to help companies scale into global enterprises.
BDC Capital Management
BDC Capital Management is an independent advisory firm specializing in values-based financial planning and objective investment management for individuals and families.
Anges Québec
Anges Québec is a prominent Canadian angel network that provides value-added capital and mentorship to innovative technology companies, fostering growth within the local ecosystem.
What's next for Hexoskin?
With this latest strategic investment, Hexoskin is poised to deepen its penetration into the global defense and aerospace markets while expanding its footprint in clinical research. The company's roadmap likely involves the enhancement of its AI-driven analytics engine to provide more predictive health outcomes, further differentiating its offerings from standard wearable devices. As the demand for remote, high-fidelity health monitoring continues to rise, Hexoskin's focus on non-invasive, scalable solutions will be instrumental in maintaining its competitive edge. The firm is expected to utilize this capital to bolster its R&D capabilities, ensuring that its sensor technology remains at the forefront of the health-tech industry's evolution.
See full Hexoskin company page
